Professor Victoria Cowling was selected by UK Research and Innovation (UKRI) as one of their case studies for the launch last week of their new prestigious £900 million Future Leaders Fellowship Scheme. In 2007, she was a recipient of UK government funding through a Medical Research Council (MRC) Career Development Award. This initial investment in Vicky to allowed her to study a cancer-causing protein called Myc. Since then she has received several million pounds’ worth of funding for her research work from a number of sources including the MRC, Lister Institute and the European Research Council. In recognition of her exceptional research, Professor Cowling has now received a Royal Society Wolfson Research Merit Award.
This scheme, jointly funded by the Wolfson Foundation and the Royal Society, is for outstanding scientists to help recruit them to or retain them in the UK. It covers all areas of the life and physical sciences, including engineering, but excluding clinical medicine.
Professor Cowling said, “I’m grateful that the work of our research team has received this recognition for our work in Dundee. This award is from the Royal Society, Wolfson Foundation and the Department for Business, Innovation and Skills (BIS) who recognise the quality of science being produced from UK universities.”
As part of the UKRI case study, Professor Cowling talked about her research on identifying other proteins targeted by Myc in cancer cells, so that new targets for drug development can be identified. The Fellowship also provided the flexibility for her to build in collaboration with the Drug Discovery Unit to use their cutting-edge technology and expertise. To hear more about how important the Fellowship was for her, watch the video here: